Sleep-related eating disorder induced by risperidone

Journal of Clinical Psychiatry

Volumn 65, Issue 2, 2004, Pages 273-274

  Lu, Mong Liang ^a   Shen, Winston W ^a  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT; RISPERIDONE;

AGED; CASE REPORT; CHEMICALLY INDUCED DISORDER; DOSE RESPONSE; HUMAN; HYPERPHAGIA; MALE; MULTIINFARCT DEMENTIA; NOTE; SLEEP WALKING;

AGED; ANTIPSYCHOTIC AGENTS; DEMENTIA, VASCULAR; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; HYPERPHAGIA; MALE; RISPERIDONE; SOMNAMBULISM;

EID: 1842834083     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v65n0220a     Document Type: Letter

References (11)

1. Paquet V, Strul J, Servais L, et al. Sleep-related eating disorder induced by olanzapine [letter]. J Clin Psychiatry 2002;63:597 (Pubitemid 34787327)
2. Lingjaerde O, Ahlfors UG, Bech P, et al. The UKU Side Effect Rating Scale: A New Comprehensive Rating Scale for Psychotropic Drugs and a Cross-Sectional Study of Side Effects in Neuroleptic-Treated Patients. Acta Psychiatr Scand Suppl 1987;76:1-100 (Pubitemid 17115352)
3. Winkelman JW. Clinical and polysomnographic features of sleep-related eating disorder. J Clin Psychiatry 1998;59:14-19 (Pubitemid 28243770)
4. Montgomery L, Haynes LC. What every nurse needs to know about nocturnal sleep-related eating disorder. J Psychosoc Nurs Ment Health Serv 2001;39:14-20
5. Schenck CH, Mahowald MW. Review of nocturnal sleep-related eating disorders. Int J Eat Disord 1994;15:343-356 (Pubitemid 24121743)
6. Winkelman JW, Herzog DB, Fava M. The prevalence of sleep-related eating disorder in psychiatric and non-psychiatric populations. Psychol Med 1999;29:1461-1466
7. Kolivakis TT, Margolese HC, Beauclair L, et al. Olanzapine-induced somnambulism [letter]. Am J Psychiatry 2001;158:1158
8. Yamashita H, Morinobu S, Yamawaki S, et al. Effect of risperidone on sleep in schizophrenia: a comparison with haloperidol. Psychiatry Res 2002;109:137-142 (Pubitemid 34258492)
9. Kapur S, Zipursky R, Remington G. Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia. Am J Psychiatry 1999;156:286-293 (Pubitemid 29077120)
10. Schenck CH, Hurwitz TD, O'Connor KA, et al. Additional categories of sleep-related eating disorders and the current status of treatment. Sleep 1993;16:457-466 (Pubitemid 23241669)
11. Wetter TC, Brunner J, Bronisch T. Restless legs syndrome probably induced by risperidone treatment. Pharmacopsychiatry 2002;35:109-111 (Pubitemid 34651917)